CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Cash & Equivalents	192.03	291.34	423.31	347.56	286.5	193.62	235.18	298.26	225.67	484.47	707.43	389.48	527.77	444.8	344.41	211.89	494.15	496.89	683.91	923.03
Short-Term Investments	2,081	2,073	2,018	1,628	1,629	1,528	1,620	1,606	1,710	1,517	1,401	1,304	1,212	1,323	1,539	1,603	1,402	1,568	1,537	1,456
Cash & Short-Term Investments	2,273	2,364	2,442	1,976	1,916	1,721	1,855	1,904	1,936	2,002	2,108	1,694	1,740	1,768	1,883	1,815	1,896	2,065	2,221	2,379
Cash Growth (YoY)	18.63%	37.36%	31.61%	3.78%	-1.03%	-14.01%	-11.99%	12.41%	11.25%	13.21%	11.95%	-6.70%	-8.24%	-14.39%	-15.22%	-23.70%	-23.47%	-20.24%	22.98%	40.75%
Accounts Receivable	-	-	-	-	-	-	-	25	-	-	-	200	-	70	-	-	0.05	0.07	0.14	0.31
Other Receivables	-	-	-	-	-	-	-	-	-	-	-	6.5	-	-	-	11.2	-	-	-	8.4
Receivables	-	-	-	-	-	-	-	25	-	-	-	206.5	-	70	-	11.2	0.05	0.07	0.14	8.71
Prepaid Expenses	12.15	7.02	6.18	5.95	9.88	8.93	8.83	8.31	8.25	8.79	11.5	7.89	20.76	21.47	24.8	26.01	32.63	37.55	34.41	29.68
Restricted Cash	0.38	0.4	0.4	3.89	3.5	3.5	3.5	-	-	-	-	-	-	-	-	0.5	4.05	4.1	4.8	-
Total Current Assets	2,285	2,372	2,448	1,986	1,929	1,734	1,868	1,937	1,944	2,010	2,120	1,908	1,761	1,860	1,908	1,853	1,933	2,107	2,261	2,418
Property, Plant & Equipment	226.91	233.66	240.85	247.58	255.49	262.57	269.7	277.55	284.83	291.57	298.51	305.94	312.34	318.52	315.54	320.56	327.62	331.93	328.99	312.04
Long-Term Investments	35.92	35.9	27.2	22.6	51.01	22.6	-	12.9	-	11.22	-	1.97	-	4.9	6.32	53.13	77.15	8.39	-	-
Other Intangible Assets	-	-	-	-	-	-	-	-	-	-	0	0.02	0.03	0.04	0.06	0.07	0.08	0.1	0.11	0.13
Other Long-Term Assets	8.51	9.44	9.41	9.4	9.71	10.88	28.79	14.45	27.41	26.66	20.88	13.57	13.88	13.97	14.48	16.28	15.81	15.88	16.45	22.2
Total Assets	2,556	2,651	2,726	2,265	2,245	2,030	2,166	2,242	2,256	2,340	2,439	2,230	2,087	2,197	2,244	2,243	2,353	2,463	2,606	2,752

Liabilities

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Accounts Payable	20.59	11.31	13.65	11.14	11.8	9.75	13.06	14.71	15.58	9.45	16.46	38.15	26.15	27.59	45.15	27.43	32.11	25.24	27.11	14.82
Accrued Expenses	29.12	30.71	28.96	34.46	24.9	27.37	28.29	39.56	35.55	39.05	27.27	40.67	38.6	40.39	36.87	61.33	95.2	73.24	65.97	77.77
Current Portion of Leases	18.68	18.65	18.61	18.58	18.26	18.03	17.51	17.29	16.88	16.45	15.99	15.63	15	14.83	15.72	15.84	11.26	8.27	11.08	12.16
Current Income Taxes Payable	0.13	0.49	0.64	1.11	3.43	0.72	1.24	0.45	0.84	0.45	1.21	0.44	0.18	0.56	0.27	0.14	4.27	3.95	2.61	0.72
Current Unearned Revenue	2.55	15.19	15.34	15.77	1.3	2.13	3.02	3.85	4.48	4.76	4.07	4.11	3.5	-	-	-	-	-	-	1.01
Other Current Liabilities	69.9	56.55	59.08	68.06	59.28	46.37	56.33	11.93	16.47	57.66	53.99	9.81	27.81	49.47	48.78	16.38	8.03	9.26	6.94	13.4
Total Current Liabilities	140.96	132.9	136.29	149.12	118.96	104.36	119.45	87.78	89.81	127.82	118.99	108.79	111.23	132.84	146.79	121.11	150.87	119.96	113.7	119.88
Long-Term Debt	586.93	586.2	585.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-Term Leases	174.21	178.9	183.56	188.17	192.77	197.43	201.85	206.41	210.66	214.85	218.94	223.01	226.59	230.34	224.55	228.18	230.9	234.16	227.9	212.87
Long-Term Unearned Revenue	-	-	-	-	12.32	12.32	12.32	12.32	12.32	12.58	13.54	14.01	15.82	12.32	12.32	12.32	12.32	12.32	12.32	12.32
Other Long-Term Liabilities	6.24	6.22	5.95	6.14	5.28	4.48	3.32	3.44	3.68	3.65	3.62	0.96	5.39	5.48	5.8	5.97	5.31	6.09	7.34	7.34
Total Liabilities	908.34	904.22	911.26	343.43	329.33	318.59	336.94	309.95	316.47	358.9	355.08	346.77	359.04	380.99	389.47	367.58	399.4	372.53	361.26	352.42

Shareholders' Equity

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Common Stock	3.15	3.13	3.12	3.09	3.01	2.79	2.72	2.7	2.68	2.67	2.66	2.5	2.48	2.47	2.45	2.44	2.43	2.42	2.41	2.39
Additional Paid-In Capital	3,932	3,910	3,884	3,862	3,725	3,415	3,324	3,294	3,255	3,224	3,199	2,878	2,821	2,799	2,761	2,735	2,709	2,670	2,635	2,598
Retained Earnings	-2,273	-2,162	-2,070	-1,948	-1,817	-1,710	-1,502	-1,366	-1,329	-1,243	-1,116	-999.7	-1,089	-976.9	-899.16	-846.09	-735.52	-560.97	-375.13	-195.92
Treasury Stock	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06
Comprehensive Income & Other	-14.08	-4.63	-1.94	4.82	4.99	4.04	4.14	1.84	10.57	-2.88	-1.55	1.91	-6.8	-8.91	-9.39	-15.65	-22.26	-20.34	-16.89	-5.07
Total Common Equity	1,648	1,747	1,815	1,922	1,916	1,711	1,829	1,932	1,940	1,981	2,084	1,883	1,728	1,816	1,855	1,875	1,954	2,091	2,245	2,399
Shareholders' Equity	1,648	1,747	1,815	1,922	1,916	1,711	1,829	1,932	1,940	1,981	2,084	1,883	1,728	1,816	1,855	1,875	1,954	2,091	2,245	2,399
Total Liabilities & Equity	2,556	2,651	2,726	2,265	2,245	2,030	2,166	2,242	2,256	2,340	2,439	2,230	2,087	2,197	2,244	2,243	2,353	2,463	2,606	2,752

Additional Metrics

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Debt	779.83	783.75	787.64	206.75	211.02	215.45	219.36	223.69	227.55	231.3	234.93	238.63	241.59	245.18	240.27	244.02	242.16	242.43	238.98	225.03
Net Cash (Debt)	1,497	1,581	1,654	1,769	1,733	1,506	1,636	1,680	1,708	1,782	1,873	1,457	1,498	1,528	1,649	1,624	1,731	1,831	1,982	2,154
Net Cash Growth (YoY)	-13.64%	4.97%	1.11%	5.29%	1.46%	-15.48%	-12.67%	15.31%	14.01%	16.61%	13.58%	-10.30%	-13.44%	-16.57%	-16.80%	-24.59%	-23.81%	-23.64%	13.61%	32.24%
Net Cash Per Share	15.47	16.38	17.22	18.57	18.98	17.29	19.04	19.66	20.04	20.98	22.90	17.92	18.87	19.32	20.96	20.74	22.19	23.63	25.71	28.10
Filing Date Shares Outstanding	97	96.69	96.45	95.99	95.3	90.95	86.36	85.77	85.35	85.17	84.92	80.28	79.43	79.41	78.94	78.65	78.29	78.01	77.46	77.07
Total Common Shares Outstanding	96.86	96.66	96.39	95.89	93.87	88.38	86.36	85.74	85.34	85.05	84.84	80.04	79.43	79.37	78.86	78.51	78.25	77.79	77.39	76.99
Working Capital	2,144	2,239	2,312	1,837	1,810	1,629	1,748	1,849	1,854	1,883	2,001	1,799	1,649	1,727	1,761	1,732	1,782	1,987	2,147	2,298
Book Value Per Share	17.02	18.07	18.83	20.04	20.41	19.36	21.18	22.53	22.73	23.29	24.56	23.52	21.75	22.88	23.52	23.89	24.97	26.88	29.01	31.17
Tangible Book Value	1,648	1,747	1,815	1,922	1,916	1,711	1,829	1,932	1,940	1,981	2,084	1,883	1,728	1,816	1,855	1,875	1,954	2,091	2,245	2,399
Tangible Book Value Per Share	17.02	18.07	18.83	20.04	20.41	19.36	21.18	22.53	22.73	23.29	24.56	23.52	21.75	22.88	23.52	23.89	24.97	26.88	29.01	31.16
Machinery	57.76	57.66	56.83	56.28	54.8	55.15	55.01	54.4	54.67	54.19	53.41	53.26	52.88	52.71	51.9	49.62	47.56	49.27	41.02	36.25
Construction In Progress	3.55	3.22	4.02	3.96	5.8	5.52	5.54	6.12	8.4	8.65	8.84	8.86	8.53	6.94	6.1	6.16	4.6	3.57	73.87	52.4
Leasehold Improvements	146.79	146.79	146.67	146.67	145.85	145.85	145.85	145.85	143.26	143.26	143.26	143.26	143.26	143.34	143.06	141.68	141.91	163.44	86.4	86.74

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error